tocacco plant Native American Tobaccoo flower, leaves, and buds

tocacco Tobacco is an annual or bi-annual growing 1-3 meters tall with large sticky leaves that contain nicotine. Native to the Americas, tobacco has a long history of use as a shamanic inebriant and stimulant. It is extremely popular and well-known for its addictive potential.

tocacco nicotina Nicotiana tabacum

tocacco Nicotiana rustica leaves. Nicotiana rustica leaves have a nicotine content as high as 9%, whereas Nicotiana tabacum (common tobacco) leaves contain about 1 to 3%

tocacco cigar A cigar is a tightly rolled bundle of dried and fermented tobacco which is ignited so that its smoke may be drawn into the mouth. Cigar tobacco is grown in significant quantities in Brazil, Cameroon, Cuba, Dominican Republic, Honduras, Indonesia, Mexico, Nicaragua, Sumatra, Philippines, and the Eastern United States.

tocacco Tobacco is an agricultural product processed from the fresh leaves of plants in the genus Nicotiana. It can be consumed, used as an organic pesticide, and in the form of nicotine tartrate it is used in some medicines. In consumption it may be in the form of cigarettes smoking, snuffing, chewing, dipping tobacco, or snus.

tocacco
Tobacco-Facts ads

Philip Morris Pushes Smokeless

Tobacco giant Philip Morris USA Inc. is urging the Food and Drug Administration to adopt a regulatory plan that would encourage smokless tobaccosmokers who can’t or won’t quit tobacco to switch to less-harmful smokeless tobacco.

Philip Morris and U.S. Smokeless Tobacco Co., both units of Altria Group Inc., said in a letter to the FDA late last month that a regulatory framework that takes into account the “continuum of risk” of different types of tobacco products could “have a significant public health benefit.”

The companies, based in Richmond, Va., filed the letter as part of a public-comment period in which the FDA accepted ideas for implementing the landmark law enacted last year that gave the agency broad authority to regulate tobacco products.

The comments place the maker of Marlboro cigarettes and Skoal moist smokeless tobacco into a complex debate over how to reduce tobacco-related harm. The new law, the Family Smoking Prevention and Tobacco Control Act, empowers the FDA to implement strategies to curtail tobacco-related illness and death.

The companies argued in the letter that regulations that permit the industry to communicate to consumers about the lower dangers of smokeless-tobacco products could complement, rather than compete with, efforts to get people to stop using tobacco or to keep them from starting.

Matthew Myers, president of the advocacy group Campaign for Tobacco-Free Kids, criticized Altria’s letter, calling it “a ploy to weaken” standards established in the tobacco-regulation law. The law sets a high bar for health-related claims, stipulating that manufacturers demonstrate that the product significantly reduces the risk of tobacco-related disease for individual users and benefits the health of the U.S. population as a whole. “This is directly counter to the legislation that they supported,” said Mr. Myers, whose group coordinated support for the legislation.

Brendan McCormick, an Altria spokesman, said Philip Morris was “very consistent” in its letter in saying that the regulatory framework be based “on science and evidence.”

Philip Morris didn’t specify the types of regulations it might like to see from the FDA. David Adelman, an industry analyst with Morgan Stanley, said the FDA, “in theory,” might place lighter advertising restrictions on smokeless-tobacco products than on cigarettes or approve warning labels that highlight the lower risks of the products, among other scenarios.

“What Altria would like, and I think Reynolds would like, is an endorsement by the government that smokeless-tobacco products do indeed have significantly less risk,” Mr. Adelman said. “That could be a real boon to the category.”

Philip Morris’s comments are similar to those by rival Reynolds American Inc., the maker of Camel cigarettes and the No. 2 industry player in the U.S. after Altria. Reynolds, in an October letter to the FDA, said “real health benefits can result from encouraging the production of, the investment in, and the migration to lower-risk products.” Reynolds makes Grizzly moist snuff and Camel Snus, a type of spit-free smokeless tobacco.

Some public-health advocates support the idea of encouraging smokers to switch to smokeless products as a way to reduce tobacco-related disease. But others strongly oppose the strategy, saying it could prompt people who otherwise would never use tobacco to become addicted to it. Many scientific studies have shown that smokeless products carry lower health risks than cigarettes.

An FDA spokeswoman declined to comment on Altria’s letter but said the agency would “carefully consider all comments submitted by all parties when implementing the many provisions of the tobacco-control act.”

By DAVID KESMODEL

Share and Enjoy:
  • Digg
  • del.icio.us
  • Facebook
  • Technorati
  • StumbleUpon
  • Google Bookmarks
  • MySpace
  • MyShare
  • RSS
  • Twitter
  • Simpy
  • Sphinn
  • Yahoo! Buzz
  • Blogosphere News
  • Mixx
  • Reddit
  • Propeller
  • MisterWong
  • LinkedIn

Related posts:

  1. Rivals pursue same goal: Reynolds American, Philip Morris prod FDA Pursuing a reduced-risk niche for smokeless-tobacco products has put archrivals...
  2. Philip Morris International 3Q profit falls RICHMOND, Va. — Cigarette maker Philip Morris International Inc., which...
  3. Tobacco regulations unfolding in Philip Morris’ favor As President Obama and a credulous media continue to portray...
  4. Philip Morris International 1Q profit rises Higher selling prices helped boost cigarette maker Philip Morris International...
  5. Philip Morris packaging now in FDA compliance Pale-blue “FDA Compliant” signs with big, red check marks are...
  6. Philip Morris to challenge ban on display of tobacco products A County Donegal shopkeeper will join forces with cigarette manufacturer...
  7. Cool, Refreshing Legislation for Philip Morris Indulge me in a thought experiment. Pretend that drinking something...
  8. Philip Morris consolidates cigarette-making operations in Richmond Tucked between the new high-speed cigarette-makers and pack-loaders in Philip...
  9. Production ends at Philip Morris USA’s N.C. plant As of this morning, Philip Morris USA’s Richmond manufacturing plant...
  10. Refreshing Legislation for Philip Morris Indulge me in a thought experiment. Pretend that drinking something...

Tobacco-Facts ads
discount cigarettes online

1 comment to Philip Morris Pushes Smokeless

  • marbee

    Big pharma Johnson & Johnson’s main shareholder and smoking ban shill, the RWJohnson Foundation, depends on it’s livlihood from J&J making and marketing cessation products. They have hoodwinked many people and gov’t officials that without smoking bans forcing 1/3 of the entire population of the U.S. and the rest of the world into submission, that smoking and second hand smoke will kill. How on earth have we survived thus far! They have spent over one Billion dollars to influence legislation to take away freedom and private property rights in the grand marketing scam of the century, along with global warming. The Surgeon General managed to avoid testifying under oath to a congressional committee along with the commissioner from the FDA. I would say that is a conflict of interest to say the least, especially with FDA regulation of tobacco. What a scam this whole thing is, shut them all down!

Leave a Reply

 

 

 

You can use these HTML tags

<a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>

*
To prove you're a person (not a spam script), type the security word shown in the picture. Click on the picture to hear an audio file of the word.
Click to hear an audio file of the anti-spam word